|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/32 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C12N 15/00 | (2006.01) |
| (11) | Number of the document | 3196213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17154607.0 |
| Date of filing the European patent application | 2006-12-29 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 755103 P | 2005-12-30 | US |
| (72) |
ROTHE, Mike , DE
TREDER, Martin , DE
HARTMANN, Susanne , DE
FREEMAN, Dan , US
RADINSKY, Bob , US
BORGES, Eric , DE
|
| (73) |
Daiichi Sankyo Europe GmbH ,
Zielstattstr. 48, 81379 München,
DE
Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (54) | ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF |
| ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF |